Securing Reimbursement for Ophthalmic Innovations in the UAE and KSA

Objective:

Collaboration with a pioneering ophthalmic enterprise specializing in groundbreaking therapies for glaucoma, corneal disorders, and retinal diseases for seamless reimbursement across the UAE and KSA public and private healthcare sectors.

Our Comprehensive Approach:

Phase I: Short-Term Strategy for Private Market (UAE and KSA)

• Coverage Optimization: Strategically resolving private sector coverage limitations
• Rejection Analysis: In-depth health insurer rejection assessments
• Stakeholder Engagement: Essential meetings with key decision-makers
• Tailored Solutions: Case-by-case reimbursement solutions

Phase II: Long-Term Strategy for Private Market (KSA)

• Value Proposition Justification: Validating therapy's value for stakeholders
• Strategic Dialogue: Early dialogues with the National Health Council
• KOL Endorsement: Involvement of influential Key Opinion Leader for optimizing the reimbursement process 
• Healthcare Reform Insights: Real-time reform insights for private coverage
• Reimbursement Proposal: Comprehensive proposal for reimbursement support
• Decision-Maker Engagement: Persistent decision-maker dialogue

Phase III: Long-term Strategy for Public Market (KSA)

• Healthcare Reform Insights: Monitoring and Presenting Public Coverage Reform Impacts
• KOL Identification: Identification of influential Key Opinion Leaders to decision-makers
• KOL Network Building: Facilitating Influential KOL Network Growth
• Holistic Reimbursement Assistance: Full-scale private and public sector support

Our dedication to fusing innovation and reimbursement empowers healthcare pioneers. Through meticulous analysis and tailored strategies, we ensure access to advanced ophthalmic therapy, showcasing our healthcare consulting expertise.